Hudson Hoagland Society
The Hudson Hoagland Society (HHS) is the leadership giving group of individuals who support biomedical research at UMass Chan Medical School with cumulative gifts of $1,000 or more to our Annual Research Fund within a fiscal year (July to June).
Philanthropy is as important to medical discovery as are the countless hours researchers spend in their labs. You can play a role in advancing toward a world free of disease.
Join HHS
Hudson Hoagland Society Membership Levels
Founder - $10,000 or more
Partner - $5,000 to $9,999
Patron - $2,500 to $4,999
Benefactor - $1,000 to $2,499
Friend - $500 to $999
HHS was originally founded in 1985 to recognize major annual contributors to the Worcester Foundation for Biomedical Research. Named in honor of the Worcester Foundation's co-founder, the Society brings together individuals who share a commitment to advancing biomedical research. Founded in 1985 as an independent research institute by Drs. Hudson Hoagland and Gregory Pincus, the Worcester Foundation merged with the University of Massachusetts Medical School in 1997. Since the time of the merger with the Worcester Foundation, and in affiliation with the Hudson Hoagland Society, more than $5 million in innovation grants of up to $40,000 have been awarded to nearly 170 researchers at UMass Chan Medical School.
Funds raised through the Hudson Hoagland Society are now used to support the most promising and innovative research at UMass Chan Medical School. These "seed" grants are awarded based on a competitive review process and allow a researcher to pursue new, innovative research for which he or she may not yet have funding. To learn more about grant recipients who have recently benefited from these funds, click here.
For more information, please contact:
Hudson Hoagland Society Annual Meeting
The 36th annual meeting held on Thursday, May 20, 2021, focused on "COVID-19: The virus, its variants and the vaccines." For the second time, the event was held online.
Fascinating presentations explaining how the sequencing of the original Sars-COV-2 genome has helped with treatment and rapid vaccine development, as well as current efforts to track the variants, were given by:
- Jeremy Luban, MD, the David J. Freelander Memorial Professor in AIDS Research and professor of molecular medicine and biochemistry & molecular pharmacology, and
- Beth McCormick, PhD, the Worcester Foundation for Biomedical Research Chair, professor and vice chair of microbiology & physiological systems, and founding director fo the UMass Center for Microbiome Research.
The virtual event was moderated by the venerable Thoru Pederson, PhD, the Vitold Arnett Professor in Cell Biology, and featured a UMass Chan update from Provost Terence R. Flotte and pre-recorded welcome remarks from Chancellor Michael F. Collins. You can view a recording of the meeting below.
